CHS-1701
CHS-1701-04
Phase 1 small_molecule completed
Quick answer
CHS-1701 for Immunity, Humoral is a Phase 1 program (small_molecule) at Coherus Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Coherus Oncology
- Indication
- Immunity, Humoral
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed